In this study, compared with L. lactis, oral administration of LL-IL-27 showed a stronger protective effect against CD4+CD45RBhi T-cell transfer-induced colitis by alleviating intestinal damage and promoting IL-10 expression in the colon. This evidence concerns the gene CD4 and colitis.